Ocular toxicity is a crucial aspect of pharmacological research and development. With the increasing complexities of both existing and new drugs, understanding how these substances affect the eyes is vital for ensuring patient safety. Creative Bioarray specializes in ocular toxicology research, providing comprehensive support for every phase of preclinical development programs.
Significance of Ocular Toxicity Assessment
The possibility of ocular side effects is prevalent with the systemic administration of various drugs. Such reactions can serve as significant markers of toxicity, necessitating their thorough evaluation. Regulatory requirements often mandate ocular toxicity assessments, ensuring any potential hazards are identified early in the drug development process. The anatomical and physiological differences among various species can significantly impact the nature of the ocular effects observed, which is crucial for designing and interpreting toxicological studies accurately.
Our Ocular Toxicology Services
Creative Bioarray offers a wide array of ocular toxicology services tailored to meet the specific needs of our clients. Our services include:
- Assessments of lacrimation
- Testing pupillary diameter
- Ocular irritation, tolerability, and sensitization studies
- Evaluations related to contact lens toxicity
- Toxicity studies involving ocular implants and punctal plugs
- Single-dose and multiple-dose ocular toxicity assessments
Advanced Techniques
We employ sophisticated methodologies to enhance the accuracy and reliability of our ocular toxicity evaluations. Techniques such as electroretinography (ERG), optical coherence tomography (OCT), pachymetry, tonometry, and fundus angiography are utilized for detailed pharmacological and toxicological assessments.
Administration Routes
Our studies consider various routes of administration, including:
- Intravitreal
- Periocular
- Subretinal
- Retrobulbar
- Intrastromal
- Anterior and posterior chamber injections
- Conjunctival or subconjunctival methods
Collaboration with Professionals
All assessments are carried out by qualified ophthalmologists, working closely with experienced pathologists. This collaboration not only ensures comprehensive interpretation of results but also adheres to the highest standards of accuracy and reliability.
Conclusion
Ocular toxicity assessments are increasingly important as the development of new pharmaceuticals continues to grow. Thorough documentation of ocular side effects, along with the investigation of other potential causes, is essential for determining causality. Creative Bioarray remains dedicated to providing exceptional support in this critical field of study. For more information about our services or to initiate a consultation, please contact us today!
